Results

Total Results: 236 records

Showing results for "lab".

161. Masks-Appendix-Table-B-1-Surveillance-Report (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/Masks-appendix-table-b-1-surveillance-report.xlsx
     April 09, 2020 - reported Fever, feeling feverish or hx of fever, ≥2 respiratory infection symptoms, or 1 symptom plus lab

162. Rapid Evidence Product: No-Touch Modalities for Disinfecting Patient Rooms in Acute Care Settings (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-review-no-touch-modalities.pdf
     May 01, 2022 - complete this rapid review in a timely fashion, the scope was narrowly defined and did not include lab

163. Ch 8-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_8-user-guide-to-ocer_130129.pdf
     October 01, 2013 - that patients with late-stage ductal adenocarcinomas were more likely to have missing biochemistry lab

164. Traumatic Brain Injury and Depression (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-brain-injury_executive.pdf
     April 01, 2011 - Traumatic Brain Injury and Depression Introduction We do not know the extent to which depression contributes to long-term disability following traumatic brain injury (TBI), although depression is one of several potential psychiatric illnesses that may be common following TBI. Major depression may be triggered by phy…

165. First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children-update-disposition-170621.pdf
     March 16, 2017 - If these factors correlate highly with weight gain or bmi then some of the lab monitoring might be

166. First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/antipsychotics-children-update-disposition-170621.pdf
     March 16, 2017 - If these factors correlate highly with weight gain or bmi then some of the lab monitoring might be

167. - (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_appendixes.pdf
     January 01, 2009 - Also, a potent inhibitor of cell apoptosis; therefore, it is used as a lab marker to evaluate cancer … Used as a lab marker to evaluated cancer risk in patients receiving recombinant human growth hormone

168. Tonsillitis | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/tonsillitis

169. Chlamydia Infections | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/chlamydia-infections

170. Disposition of Comments Report for Vitamin D and Calcium: A Systematic Review of Health Outcomes (Update) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/vitamin-d-calcium_disposition-comments.pdf
     September 15, 2014 - Again, it was beyond the scope of the review to include lab animal studies. 31 Peer Reviewer 3 Introduction

171. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-applicability.ppt
     June 01, 2012 - practice: Primary care versus specialty care Hospital-based Routine processing versus specialized lab

172. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-applicability.ppt
     June 01, 2012 - practice: Primary care versus specialty care Hospital-based Routine processing versus specialized lab

173. Making Healthcare Safer IV: Summary of Findings, 2023-2024 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-1-year-final-report-updated-title_0.pdf
     May 01, 2024 - Barriers, Facilitators, and Resources o Implementing ASC programs can be resource-intensive; staff time, lab

174. FRN 35 - Preventive Pharmacological Treatments for Migraine in Adults: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-future_research.pdf
     April 01, 2013 - diagnosis and therefore inclusion in intervention studies, as opposed to conditions that use definitive lab … diagnosis and therefore inclusion in intervention studies, as opposed to conditions that use definitive lab

175. Disposition of Comments for Pressure Ulcer Treatment Strategies: Comparative Effectiveness (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pressure-ulcer-treatment_disposition-comments.pdf
     May 08, 2013 - This is one of the hottest topics in pressure ulcer research and, although these tend to be lab and … validated and approved by the NPUAP’s Support Surface We appreciate your submission, but the lab

176. Disposition of Comments Report for Comparative Effectiveness of Bariatric Surgery and Nonsurgical Therapy in Adults With Metabolic Conditions and a Body Mass Index of 30.0 to 34.9 kg/m2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/weight-loss-surgery_disposition-comments.pdf
     June 05, 2013 - Disposition of Comments Report for Comparative Effectiveness of Bariatric Surgery and Nonsurgical Therapy in Adults With Metabolic Conditions and a Body Mass Index of 30.0 to 34.9 kg/m2 Comparative Effectiveness Research Review Disposition of Comments Report Research Review Title: Comparative Effectiveness …

177. Methods-Guide-Chapter-Prioritization-And-Selection-Of-Harms-For-Inclusion-In-Systematic-Reviews (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prioritization-selection-of-harms.pdf
     February 01, 2018 - either the patient or clinician consider to be serious, or organized by category [e.g., diagnosed by lab

178. Disposition of Comments for CER 172 Clostridium Difficile Diagnosis Prevention Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/c-difficile-update_disposition-comments.pdf
     March 29, 2016 - section there should be some acknowledgement that the choice of test may also be altered by the type of lab

179. Disposition of Comments for Pharmacokinetic/Pharmacodynamic Measures for Guiding Antibiotic Treatment for Hospital-Acquired Pneumonia (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pneumonia-antibiotic-treatment_disposition-comments.pdf
     November 24, 2014 - defined in infectious diseases trials as “clinicians’ judgments regarding signs, symptoms, radiology and lab

180. Cer-238-Cervical-Ripening-Appendix-E-2 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-238-cervical-ripening-appendix-e-2.xlsx
     January 01, 2017 - NR Infection (neonatal suspected sepsis: ≥1 symptom, 1 abnormal lab test, and antibiotic response):